Opioid - Page 1 | CARLAT PUBLISHING

“I Just Click Through the Warnings”: When EHR Alerts Become a Liability

October 5, 2025

This month in The Carlat Psychiatry Report, Jason Mallo, DO, breaks down the drug interactions that actually matter—the ones that carry real clinical consequences, and the ones that are often missed.

A New FDA Approval Brings New Psychiatric Risks

September 1, 2025

Chris Aiken, MD and Kellie Newsome, PMHNP

The FDA just approved the cyclobenzaprine (Tonmya, Flexeril) for fibromyalgia. We look at three risks that medication raises in psychiatry.

Fact Sheet

Opioid Use Disorder in Older Adults

August 2, 2025

Rehan Aziz, MD

Dr. Aziz has no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Opioid Use Disorders (OUDs) are increasingly prevalent in older adults.

Fact Sheet

Contingency Management for Opioid Use Disorder

January 1, 2025

Noah Capurso, MD, MHS, Talia Puzantian, PharmD, BCPP, and Daniel Carlat, MD

Dr. Hendrick and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Contingency management (CM) is a strategy based on rewarding positive behaviors to encourage change.

Fact Sheet

12-Step Programs and Opioid Use Disorder

January 1, 2025

Noah Capurso, MD, MHS, Talia Puzantian, PharmD, BCPP, and Daniel Carlat, MD

Dr. Capurso, Dr. Hendrick, and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

12-step peer support groups such as Alcoholics Anonymous (AA) or Narcotics Anonymous (NA) are associated with better outcomes for those already taking medication for opioid use disorder (MOUD)

Expert Q&A

Addressing the Overdose Crisis: What You Can Do

January 1, 2025

Aaron Quiggle, MD, MS

Aaron Quiggle, MD, MS

Adult, child, and adolescent addiction psychiatrist; Medical Director, Addiction Recovery Management Service (ARMS), Massachusetts General Hospital, Boston, MA.

Dr. Quiggle is a co-investigator of an investigator-sponsored trial for Ironshore Pharmaceuticals. Relevant financial relationships have been mitigated.

There are multiple ways that we can help our patients reduce the risk of overdose. In our interview with Dr. Aaron Quiggle, we cover screening, fentanyl testing, the use of Narcan and the importance of learning to prescribe buprenorphine.

Fact Sheet